Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jieyu Capsule is a Traditional Chinese Medicine (TCM) product developed and manufactured by China Resources Sanjiu Medical & Pharmaceutical. It is primarily indicated for the treatment of mild to moderate depression. The formulation consists of extracts from *Hypericum perforatum* (St. John's Wort) and *Acanthopanax senticosus* (Siberian Ginseng). The therapeutic effect is largely driven by the active constituents of *Hypericum perforatum*, such as hypericin and hyperforin, which act as non-selective reuptake inhibitors of monoamine neurotransmitters, including serotonin, norepinephrine, and dopamine. *Acanthopanax senticosus* is included for its adaptogenic properties, helping to improve physical and mental resilience. In TCM theory, it is used to soothe the liver and resolve stagnation, addressing symptoms associated with liver qi stagnation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jieyu Capsule (China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.).